Graham Cooper is listed as a director on 4 SEC Form D filings by 3 issuers between Oct 2013 and Jan 2019: Unity Biotechnology, Inc. (Brisbane, CA — pharmaceuticals — 2017–2018; $151.2M reported sold to 38 investors), Eiger BioPharmaceuticals, Inc. (Palo Alto, CA — biotechnology — 2013; $21.8M reported sold to 24 investors) and Bioniz Therapeutics, Inc. (Irvine, CA — biotechnology — 2019; $15.6M reported sold to 15 investors).
What this means A repeat sponsor — 3 separate companies raised money with this person listed as director, over about 6 years. Across those companies the filings report $188.6M sold in total.
Listed alongside Camille Samuels (2 shared filings), Dan Marquess (2 shared filings), Jamie Dananberg (2 shared filings), Keith Leonard (2 shared filings), Kristina Burow (2 shared filings) and 24 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Graham. Each name links to their own page.
The issuers belong to 2 sponsor groups: Eiger Biopharmaceuticals (2 issuers, $9M reported sold, 2009–2016) and Bioniz (2 issuers, $8.72M reported sold, 2013–2019).
What this means This person is listed across more than one sponsor team; each group page shows that team's full track record.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, LA, ME, MO, MS, MT, NASAA, NC, NH, NM, OR, RI, TX, WA) — 2 bankruptcy cases matching the name listed in Key records below.
What this means 2 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 4 public filings for Graham Cooper and found 6 differences: Graham Cooper appears on 1 deal that stopped filing before reaching its target; No amendment in the last 12 months on an offering that may still be open; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.